Scholarlink

<p>Ventricular arrhythmias, particularly ventricular fibrillation, remain a leading cause of sudden cardiac death and pose persistent clinical challenges due to limitations in targeted therapy and the complexity of arrhythmogenic substrates. multimodal nanotechnology has emerged as a promising platform enabling integrated diagnostic and therapeutic functions; however, direct evidence for its application in cardiology remains limited compared to oncology, and significant translational barriers persist. Concurrently, comprehensive nursing and standardized management are critical for optimizing patient outcomes through continuous monitoring, timely intervention, and holistic care. This review critically synthesizes current evidence on multimodal nanotechnology applications in ventricular arrhythmia management, distinguishing between established cardiovascular findings and conceptual extrapolations from other fields. It analyzes technological advantages alongside cardiac-specific limitations—including myocardial targeting challenges, pro-arrhythmic risks, and regulatory complexity. Furthermore, it examines how nanotechnology-based therapies will impact nursing workflows, monitoring protocols, and competency requirements, proposing a framework for integrating these innovations with standardized nursing management. By bridging cutting-edge technological advances with clinical nursing strategies, this article provides a theoretical foundation and practical guidance for fostering multidisciplinary collaboration and advancing comprehensive, patient-centered treatment paradigms for ventricular arrhythmias.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Application of multimodal nanotechnology and standardized nursing management in ventricular arrhythmia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月17日

查看全文
  • Xueqin Ding,
  • Lianghong Zhang,
  • Fangming Guo,
  • Xuhong Pan,
  • Xiaona Wei,
  • Lingfei Su,
  • Ling Wu,
  • Li Min,
  • Ming Zhang,
  • Li Han

摘要

Ventricular arrhythmias, particularly ventricular fibrillation, remain a leading cause of sudden cardiac death and pose persistent clinical challenges due to limitations in targeted therapy and the complexity of arrhythmogenic substrates. multimodal nanotechnology has emerged as a promising platform enabling integrated diagnostic and therapeutic functions; however, direct evidence for its application in cardiology remains limited compared to oncology, and significant translational barriers persist. Concurrently, comprehensive nursing and standardized management are critical for optimizing patient outcomes through continuous monitoring, timely intervention, and holistic care. This review critically synthesizes current evidence on multimodal nanotechnology applications in ventricular arrhythmia management, distinguishing between established cardiovascular findings and conceptual extrapolations from other fields. It analyzes technological advantages alongside cardiac-specific limitations—including myocardial targeting challenges, pro-arrhythmic risks, and regulatory complexity. Furthermore, it examines how nanotechnology-based therapies will impact nursing workflows, monitoring protocols, and competency requirements, proposing a framework for integrating these innovations with standardized nursing management. By bridging cutting-edge technological advances with clinical nursing strategies, this article provides a theoretical foundation and practical guidance for fostering multidisciplinary collaboration and advancing comprehensive, patient-centered treatment paradigms for ventricular arrhythmias.